ASPE: FMR reports 11.2% stake in Aspen Neuroscience
FMR LLC reports a 3,250,000-share stake in Aspen Neuroscience, 11.2% of common stock, held with sole voting and dispositive power.
What this filing says
FMR LLC, the Fidelity investment manager, reports it holds 3,250,000 shares of Aspen Neuroscience common stock, or 11.2% of the class, with sole voting and dispositive power. The filing is a passive ownership disclosure under Schedule 13G, so it signals a large institutional holder rather than an announced plan to influence the company. The event date listed is 10/30/2026.
Key figures
- Shares beneficially owned
- 3,250,000 shares
- Percent of class
- 11.2%
- Event date
- 10/30/2026
Positive for shareholders
- A large institutional manager holds a sizable position in the company.
Negative for shareholders
- The filing reports no change in intent, so the stake alone does not show what the holder will do next.
Written by Quantisnow AI from this filing. Not financial advice.
Key terms
- Schedule 13G:
- A short SEC filing used by passive investors to disclose that they own more than 5% of a company's shares.
- Beneficial ownership:
- Control over shares through voting or sale power, whether or not the shares are held directly in the holder's name.
- CUSIP:
- A nine-character identifier assigned to each security to standardize trading and record keeping.
FAQ
How much of Aspen Neuroscience does FMR LLC own?
FMR LLC reports beneficial ownership of 3,250,000 shares, which the filing states is 11.2% of Aspen Neuroscience's common stock.
Does FMR LLC plan to take control of Aspen Neuroscience?
The filing is made under Rule 13d-1(c) for passive holders and does not describe any plan to influence control of the company.
Keep researching ASPE
- What is Schedule 13G?A short-form SEC disclosure for investors who own more than 5% of a company's voting stock but hold it passively, without intent to influence control.
- Schedule 13D vs 13GSchedule 13D vs 13G explained: who must file when crossing 5% ownership, the 2024 deadlines, how activists differ from passive holders, and what Item 4 reveals.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2026
Follow ASPE and get a push notification the moment its next story breaks.